BioCryst deal

BioCryst Pharmaceuticals Inc. (BCRX) BCRX (Birmingham, Ala.) and the University of Alabama at Birmingham will develop inhibitors of the influenza neuraminidase enzyme to treat influenza. The enzyme i...